Literature DB >> 12169182

Prevalence of occupational allergy to Chrysanthemum pollen in greenhouses in the Netherlands.

G C M Groenewoud1, N W de Jong, A Burdorf, H de Groot, R Gerth van Wÿk.   

Abstract

BACKGROUND: An increasing number of allergic complaints appear to have occurred among Chrysanthemum greenhouse employees. The aim of this study was to estimate the prevalence of work-related allergic symptoms and the prevalence of sensitization to pollen of different members of the Chrysanthemum family.
METHODS: We studied 104 employees who were invited to answer an extensive questionnaire and to complete a rhinitis quality of life questionnaire. In addition, they were skin prick tested on location with inhalant allergens and home-made pollen extracts of seven different members of the Chrysanthemum family. Radio-allergo-sorbent tests were performed to confirm IgE-mediated reactions.
RESULTS: Work-related symptoms were reported in 56.7% of all cases, with the main symptom being rhinitis. Sensitization to Chrysanthemum pollen was found in 20.2% of the employees without one member of the Chrysanthemum family in particular being most prevalent. Sensitization to Chrysanthemum pollen was considered to be an important risk factor for the occurrence of work-related symptoms of the upper airways. Furthermore, inhalant atopy as well as sensitization to common airborne pollen including mugwort were closely associated with sensitization to Chrysanthemum what might be suggestive for cross-sensitization.
CONCLUSIONS: There is a high prevalence of work-related symptoms in Chrysanthemum greenhouses. In one-third of the employees these symptoms were caused by an IgE-mediated allergy caused by the pollen of the flowers. Inhalant atopy appeared to have a great impact on the development of such a sensitization. Measurements to reduce the pollen exposure are necessary to prevent a further increase of this occupational allergy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12169182     DOI: 10.1034/j.1398-9995.2002.23725.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  8 in total

1.  Review of NIOSH Cannabis-Related Health Hazard Evaluations and Research.

Authors:  James R Couch; George Reed Grimes; Brett J Green; Douglas M Wiegand; Bradley King; Mark M Methner
Journal:  Ann Work Expo Health       Date:  2020-08-06       Impact factor: 2.179

2.  Microbial hazards during harvesting and processing at an outdoor United States cannabis farm.

Authors:  Brett J Green; James R Couch; Angela R Lemons; Nancy C Burton; Kerton R Victory; Ajay P Nayak; Donald H Beezhold
Journal:  J Occup Environ Hyg       Date:  2018-05       Impact factor: 2.155

3.  Morphological and physiological differences between dehiscent and indehiscent anthers of Chrysanthemum morifolium.

Authors:  Jiangsong Fei; Sue Tan; Fengjiao Zhang; Lichun Hua; Yuan Liao; Weimin Fang; Fadi Chen; Nianjun Teng
Journal:  J Plant Res       Date:  2016-08-04       Impact factor: 2.629

Review 4.  Emerging Insights into the Occupational Mycobiome.

Authors:  Brett J Green
Journal:  Curr Allergy Asthma Rep       Date:  2018-09-27       Impact factor: 4.806

5.  An aerobiological perspective in allergy and asthma.

Authors:  Anand Bahadur Singh; Chandni Mathur
Journal:  Asia Pac Allergy       Date:  2012-07-25

6.  Factors affecting quantity of pollen dispersal of spray cut chrysanthemum (Chrysanthemum morifolium).

Authors:  Xiao-Guang Wang; Hai-Bin Wang; Fa-Di Chen; Jia-Fu Jiang; Wei-Min Fang; Yuan Liao; Nian-Jun Teng
Journal:  BMC Plant Biol       Date:  2014-01-06       Impact factor: 4.215

Review 7.  Rare and new occupational inhalant allergens.

Authors:  M Raulf-Heimsoth; I Sander; S Kespohl; V van Kampen; T Brüning
Journal:  Allergol Select       Date:  2017-08-04

8.  Transcriptome Profiling Unravels a Vital Role of Pectin and Pectinase in Anther Dehiscence in Chrysanthemum.

Authors:  Qian Li; Ze Wu; Huijun Wu; Weimin Fang; Fadi Chen; Nianjun Teng
Journal:  Int J Mol Sci       Date:  2019-11-22       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.